opens up as big pharma begins direct to consumer sales.
Some major pharmaceutical companies are getting into the telehealth business. That could allow patients to skip a visit with their regular doctor and let companies sell their drugs directly to consumers. But is that a good idea? NPR pharmaceuticals correspondent Sydney Lupkin reports.
Some major pharmaceutical companies are getting into the telehealth business. That could allow patients to skip a visit with their regular doctor and let companies sell their drugs directly to consumers. But is that a good idea? NPR pharmaceuticals correspondent Sydney Lupkin reports.